CD44 and breast carcinoma: Interestingly, the extent of reduction of CD44+/CD24− breast cancer stem cells, multi drug resistance protein 1 (MDR1), programmed death ligand-1(PD-L1) expressing cells were far less than that due to SF seen in Fig. 2g.